Nyrada Completes Preclinical Studies for Cholesterol-Lowering Program
• All required preclinical safety and toxicology studies have been completed, supporting advancement to a first-in-human clinical trial • Submission… Read more
Nyrada Quarterly Activities Report & Appendix 4C
Highlights: • Cholesterol-Lowering Program: – Preclinical dose formulation work finalised – Remaining safety and pharmacology studies to be completed end… Read more